Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

ABSTRACT:

SUBMITTER: Attard G 

PROVIDER: S-EPMC8811484 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature